NCT03512860View on ClinicalTrials.gov

Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 12, 2018

Primary Completion Date

October 8, 2018

Study Completion Date

October 8, 2018

Conditions
Contraception
Interventions
DRUG

E4/DRSP

Administered as specified in the treatment arm.

DRUG

VAL

Administered as specified in the treatment arm.

Trial Locations (1)

NG11 6JS

Quotient Sciences, Ruddington

Sponsors

Lead Sponsor

Estetra
All Listed Sponsors
collaborator

Quotient Sciences

INDUSTRY

lead

Estetra

INDUSTRY

NCT03512860 - Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study | Biotech Hunter | Biotech Hunter